Designing of Anti-Cancer Drug Targeted to Bcl-2 Associated Athanogene (BAG1) Protein
None
Saved in:
| Main Authors: | Kumar, Amit, Verma, Kriti, Sinha, Amita |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2011
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/22517 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of three-bag and single-bag protocols in rapid drug desensitization with chemotherapeutic and biological agents
by: Ozcan Gul, MD, et al.
Published: (2025-07-01) -
BCL careers /
by: Henson, Rick
Published: (1979) -
Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors
by: Dongyue Jiao, et al.
Published: (2025-07-01) -
Targeting HASPIN kinase disrupts SR protein–mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
by: Mengdan Liu, et al.
Published: (2025-08-01) -
Active Learning for Medical Article Classification with Bag of Words and Bag of Concepts Embeddings
by: Radosław Pytlak, et al.
Published: (2025-07-01)


